Studijní program
Předměty
Publikace
- Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs)2016 | Farmaceutická fakulta v Hradci Králové
- Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine2016 | Farmaceutická fakulta v Hradci Králové
- Effect of drug efflux transporters on placental transport of antiretroviral agent abacavir2015 | Farmaceutická fakulta v Hradci Králové
- Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro2015 | Farmaceutická fakulta v Hradci Králové
- Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro2015 | Farmaceutická fakulta v Hradci Králové
- Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta2014 | Farmaceutická fakulta v Hradci Králové
- Organic Cation Transporter 3 (OCT3/SLC22A3) and Multidrug and Toxin Extrusion 1 (MATE1/SLC47A1) Transporter in the Placenta and Fetal Tissues: Expression Profile and Fetus Protective Role at Different Stages of Gestation2013 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics2013 | Farmaceutická fakulta v Hradci Králové
- Olomoucine II, but Not Purvalanol A, Is Transported by Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1)2013 | Farmaceutická fakulta v Hradci Králové
- Purvalanol A, Olomoucine II and Roscovitine Inhibit ABCB1 Transporter and Synergistically Potentiate Cytotoxic Effects of Daunorubicin In Vitro2013 | Farmaceutická fakulta v Hradci Králové
Loading network view...